AlphaMol Science

Biotechnology Research • Switzerland • 1-10 Employees

Company overview

Headquarters	Switzerland
Website	alphamol.com
NAICS	541714
Employees	1-10
Socials

Key Contact at AlphaMol Science

Shuguang Yuan

Co-Founder

AlphaMol Science Email Formats

AlphaMol Science uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@alphamol.com), used 100% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@alphamol.com	100%

About AlphaMol Science

AlphaMol combines computational methods and in-house cutting-edged biotechnology, aiming at advancing pre-clinical GPCR drug discovery in an ultimately efficient way. AlphaMol has invented three first-in-class PCC within 3-9 months, which usually takes 5-7 years to achieve via traditional way. G protein-coupled receptors (GPCRs) are the most important drug targets. About 40% of the marketed drugs are targeting at GPCRs. Almost all important diseases are related to GPCRs directly, including Alzheimer's disease, cancer, diabetes, pain, depression, auto-immune, infections and many others. AlphaMol established a dedicated GPCR-purposed platform for drug discovery. In the GPCR-DOCK 2021 global contest, AlphaMol defeated Google's AlphaFold2 for the five nominated targets, with 60% higher accuracy. In 2022, AlphaMol obtained the best outstanding award in NVIDIA Inception contest for startups. In the same year, both co-founders of AlphaMol, Prof. Shuguang Yuan and Prof. Horst Vogel were in the list of "top 2%" scientists in the world.

AlphaMol Science revenue & valuation

Annual revenue	$256,665
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$821,328
Total funding	No funding